Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Merck
Express Scripts
Healthtrust
Fish and Richardson
Federal Trade Commission
AstraZeneca
QuintilesIMS
Dow

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 064065

« Back to Dashboard

NDA 064065 describes OTICAIR, which is a drug marketed by Bausch And Lomb and Pharmafair and is included in two NDAs. It is available from twelve suppliers. Additional details are available on the OTICAIR profile page.

The generic ingredient in OTICAIR is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 064065
Tradename:OTICAIR
Applicant:Bausch And Lomb
Ingredient:hydrocortisone; neomycin sulfate; polymyxin b sulfate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 064065
Suppliers and Packaging for NDA: 064065
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OTICAIR hydrocortisone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OTIC 064065 ANDA Major Pharmaceuticals 0904-3017 0904-3017-10 1 BOTTLE, DROPPER in 1 CARTON (0904-3017-10) > 10 mL in 1 BOTTLE, DROPPER
OTICAIR hydrocortisone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OTIC 064065 ANDA Bausch & Lomb Incorporated 24208-635 24208-635-62 1 BOTTLE, DROPPER in 1 CARTON (24208-635-62) > 10 mL in 1 BOTTLE, DROPPER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION/DROPS;OTICStrength1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
Approval Date:Aug 28, 1996TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Fish and Richardson
Queensland Health
Cerilliant
Daiichi Sankyo
McKesson
Johnson and Johnson
Mallinckrodt
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot